Peter Crooks


May 25, 2018

UAMS Scientist Crooks Honored by Cancer Institute Auxiliary

Susan Van Dusen

Peter Crooks, Ph.D., D.Sc., was honored by the UAMS Winthrop P. Rockefeller Cancer Institute for his achievements in drug development.

May 25, 2018 | The process of creating new drug therapies is completely foreign to most people. But for UAMS’ Peter Crooks, Ph.D., D.Sc., it’s just another day at the office.


April 18, 2017

UAMS’ Peter Crooks, Ph.D., D.Sc. Named Fellow of the National Academy of Inventors

Ben Boulden

April 18, 2017 | Peter Crooks, Ph.D., D.Sc., chair and professor of the Department of Pharmaceutical Sciences in the University of Arkansas for Medical Sciences (UAMS) College of Pharmacy, recently was named a Fellow of the National Academy of Inventors (NAI). Being named a Fellow recognizes NAI members who have, according to the academy, “demonstrated…


October 5, 2016

UAMS’ Sue Griffin, Ph.D., Awarded $10 Million by NIH for Alzheimer’s Research

Ben Boulden

Oct. 5, 2016 | Sue Griffin, Ph.D., an internationally known Alzheimer’s disease researcher at the University of Arkansas for Medical Sciences (UAMS), leads a team that has received a five-year, $10 million grant from the National Institutes of Health (NIH) to study the causes and possible treatments for Alzheimer’s disease. Griffin said the research team…


September 8, 2016

UAMS Researchers David Ussery, Hong-yu Li Named ARA Scholars

Ben Boulden

Sept. 8, 2016 | UAMS biomedical informatics researcher David Ussery, Ph.D., and UAMS cancer treatment researcher Hong-yu Li, Ph.D., were named Arkansas Research Alliance (ARA) Scholars at a news conference today at the State Capitol. Ussery and Li each were presented with a certificate by Gov. Asa Hutchinson, ARA Board of Trustees Chair Sonja Hubbard…


August 3, 2015

UAMS Part of Arkansas Consortium Awarded $20 million by National Science Foundation

Ben Boulden

Aug. 3, 2015 | The University of Arkansas for Medical Sciences (UAMS) is part of a consortium of Arkansas institutions that has been awarded a five-year, $20 million grant from the National Science Foundation (NSF) to support research and development of novel, functional surfaces produced using innovative materials and having nano-sized structures and features.


March 9, 2015

Rare Disease Discoveries Showcased at UAMS

ChaseYavondaC

March 9, 2015 | The fruitions of medical research were touted at a recent reception at UAMS focusing on rare diseases, including ALS and a form of non-Hodgkins lymphoma.


August 27, 2014

UAMS Myeloma Institute Director Gareth Morgan, M.D., Ph.D., Named ARA Scholar

Ben Boulden

Aug. 27, 2014 | Gareth Morgan, M.D., Ph.D., director of the University of Arkansas  for Medical Sciences (UAMS) Myeloma Institute for Research and Therapy, was named an Arkansas Research Alliance (ARA) Scholar at a news conference today at the State Capitol.


September 24, 2013

Cancer Drug Developed by UAMS Professor Receives FDA Approval

Ben Boulden

Sept. 24, 2013 | Valchlor, a breakthrough gel for treating lymphoma developed with the help of University of Arkansas for Medical Sciences (UAMS) College of Pharmacy Professor Peter Crooks, Ph.D., recently won marketing approval from the U.S. Food and Drug Administration.


Cancer Drug Developed by UAMS Professor Awarded FDA Approval

Ben Boulden

LITTLE ROCK — Valchlor, a breakthrough gel for treating lymphoma developed with the help of University of Arkansas for Medical Sciences (UAMS) College of Pharmacy Professor Peter Crooks, Ph.D., recently won marketing approval from the U.S. Food and Drug Administration.